Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

Brunn GJ, Hudson CC, Sekulić A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC, Abraham RT · 1997 · Science · Atlas ID BRU1997

What this study shows

mTOR directly phosphorylates 4E-BP1 (PHAS-I), releasing eIF4E and establishing mTOR's role in translational control.

Abstract

ShowHide

The immunosuppressant rapamycin interferes with G1-phase progression in lymphoid and other cell types by inhibiting the function of the mammalian target of rapamycin (mTOR). mTOR was determined to be a terminal kinase in a signaling pathway that couples mitogenic stimulation to the phosphorylation of the eukaryotic initiation factor (eIF)-4E-binding protein, PHAS-I. The rapamycin-sensitive protein kinase activity of mTOR was required for phosphorylation of PHAS-I in insulin-stimulated human embryonic kidney cells.

Read the full abstract on PubMed →

At a glance

Evidence type M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: HEK293; in vitro) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is.
Study type5 - Mechanistic / In Vitro
Model systemHEK293; in vitro
JournalScience
Year1997
Peer reviewedYes
Record last updated2026-10-01
SourceDOI 10.1126/science.277.5322.99 · PMID 9204908

Extracted findings

These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.

InterventionBiochemical (mTOR/PHAS-I)
TargetmTOR / PHAS-I (4E-BP1) / eIF4E
ModelHEK293; in vitro
EffectmTOR is a terminal kinase phosphorylating the translational repressor PHAS-I (4E-BP1)

In the Atlas

Related topics

eIF4ERapamycinmTOR4E-BP1

Links in the pathway map

More studies on this topic

Cite this paper

ShowHide
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997). Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. https://doi.org/10.1126/science.277.5322.99

@article{BRU1997,
  author       = {Brunn, G. J. and Hudson, C. C. and Sekulić, A. and Williams, J. M. and Hosoi, H. and Houghton, P. J. and Lawrence, J. C. and Abraham, R. T.},
  title        = {{Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin}},
  journal      = {Science},
  year         = {1997},
  doi          = {10.1126/science.277.5322.99},
  note         = {PMID: 9204908},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper.

Barton, O. (2026). Oliver's mTOR Atlas (record BRU1997) [Data set]. https://mtor-atlas.org/study/BRU1997/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_BRU1997,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record BRU1997},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/BRU1997/},
  doi          = {10.5281/zenodo.22059963}
}
Was this page useful?